Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Zika Vaccine Enters Clinical Trials

Zika Vaccine Enters Clinical Trials News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious Diseases by the Centers for Disease Control and Pre- (NIAID) at the National Institutes of Health vention (CDC), requires 2 to 3 days for re- (NIH) is entering phase 1 clinical trials. sults and can only be conducted in CDC- At least 80 people between the ages of designated laboratories. Contrastingly, the 18 and 35 years will be enrolled in the trial, new diagnostic test could be used in com- which will take place at 3 study sites in the mercial and health care facility laborato- United States including the NIH Clinical Cen- ries, significantly expanding Zika testing. ter in Bethesda, Maryland. The trial will test “Doctors and patients need Zika test re- vaccine safety and immunogenicity. sultsquicklysothathealthcareproviderscan Scientists at NIAID’s Vaccine Research offer appropriate guidance and treatment to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Zika Vaccine Enters Clinical Trials

JAMA , Volume 316 (12) – Sep 27, 2016

Zika Vaccine Enters Clinical Trials

Abstract

News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious...
Loading next page...
 
/lp/american-medical-association/zika-vaccine-enters-clinical-trials-0e1DHCwlUF
Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2016.12760
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious Diseases by the Centers for Disease Control and Pre- (NIAID) at the National Institutes of Health vention (CDC), requires 2 to 3 days for re- (NIH) is entering phase 1 clinical trials. sults and can only be conducted in CDC- At least 80 people between the ages of designated laboratories. Contrastingly, the 18 and 35 years will be enrolled in the trial, new diagnostic test could be used in com- which will take place at 3 study sites in the mercial and health care facility laborato- United States including the NIH Clinical Cen- ries, significantly expanding Zika testing. ter in Bethesda, Maryland. The trial will test “Doctors and patients need Zika test re- vaccine safety and immunogenicity. sultsquicklysothathealthcareproviderscan Scientists at NIAID’s Vaccine Research offer appropriate guidance and treatment to

Journal

JAMAAmerican Medical Association

Published: Sep 27, 2016

There are no references for this article.